By DEALBOOK
Glass Lewis & Company, the proxy advisory firm, is recommending that Allergan shareholders support Pershing Square Capital Management’s push for a special meeting of shareholders as part of its joint bid with Valeant Pharmaceuticals to acquire the Botox maker.
Published: August 5, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1uiRslD
from WordPress http://ift.tt/1y1OL8o
via Hadi Aboukhater
No comments:
Post a Comment